Cargando…

P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12

PURPOSE: Glioblastoma multiforme (GBM) is an aggressive brain tumor with a rather short survival time. Mutation of p53 has been observed and reported to play critical roles in the progression of GBM. However, the pathological mechanisms are still unclear. This study was designed to identify the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Gang, Yang, Shirong, Wang, Ronglin, Lei, Jie, Ji, Peigang, Wang, Jiancai, Tao, Kai, Yang, Chen, Ge, Shunnan, Wang, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924251/ https://www.ncbi.nlm.nih.gov/pubmed/33664574 http://dx.doi.org/10.2147/NDT.S273578

Ejemplares similares

Off-target effect of the BMI1 inhibitor PTC596 drives epithelial-mesenchymal transition in glioblastoma multiforme
por: Flamier, Anthony, et al.
Publicado: (2020)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme
por: Wang, Liang, et al.
Publicado: (2022)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer
por: Zhou, Q, et al.
Publicado: (2016)

MiR-145 inhibits the epithelial-to-mesenchymal transition via targeting ADAM19 in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017)

p53 regulates the mevalonate pathway in human glioblastoma multiforme
por: Laezza, C, et al.
Publicado: (2015)

Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme
por: Lee, Hsun-Hua, et al.
Publicado: (2019)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

miR-154 Influences HNSCC Development and Progression through Regulation of the Epithelial-to-Mesenchymal Transition Process and Could Be Used as a Potential Biomarker
por: Tomaszewska, Weronika, et al.
Publicado: (2021)

Super-enhancer-driven AJUBA is activated by TCF4 and involved in epithelial-mesenchymal transition in the progression of Hepatocellular Carcinoma
por: Zhang, Chi, et al.
Publicado: (2020)

miR-126 targeting GOLPH3 inhibits the epithelial-mesenchymal transition of gastric cancer BGC-823 cells and reduces cell invasion
por: Ouyang, Jiancai, et al.
Publicado: (2020)

Radioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway
por: Tian, Yunhong, et al.
Publicado: (2015)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma
por: Wang, Xingqiang, et al.
Publicado: (2017)

Estradiol Induces Epithelial to Mesenchymal Transition of Human Glioblastoma Cells
por: Hernández-Vega, Ana M., et al.
Publicado: (2020)

MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
por: Setlai, Botle Precious, et al.
Publicado: (2022)

PARK2 negatively regulates the metastasis and epithelial-mesenchymal transition of glioblastoma cells via ZEB1
por: Wang, Haiyang, et al.
Publicado: (2017)

Prognostic and Predictive Factors in Elderly Patients With Glioblastoma: A Single-Center Retrospective Study
por: Liu, Jinghui, et al.
Publicado: (2022)

Human Endogenous Retroviruses in Glioblastoma Multiforme
por: Yuan, Zihao, et al.
Publicado: (2021)

Human Glioblastoma Multiforme: p53 Reactivation by a Novel MDM2 Inhibitor
por: Costa, Barbara, et al.
Publicado: (2013)

PD-L1 Expression Correlated with p53 Expression in Pediatric Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2021)

MiR-145 inhibits EGF-induced epithelial-to-mesenchymal transition via targeting Smad2 in human glioblastoma
por: Chen, Weijie, et al.
Publicado: (2019)

TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma
por: Xu, Xu, et al.
Publicado: (2023)

PGC1α Cooperates with FOXA1 to Regulate Epithelial Mesenchymal Transition through the TCF4-TWIST1
por: Fang, Xue-Quan, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_15cljltvrpstb6vb2huulje9cm